Balanced news tone
News Sentiment
950210 sentiment intelligence
Prestige BioPharma Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-4.8% over one week, -17.2% over four weeks, trend inactive, and below fair value.
Prestige Biopharma to Attend 'BIO USA 2026'... Aiming for Global Market Expansion
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Prestige Biopharma to Attend 'BIO USA 2026'... Aiming for Global Market Expansion
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jun 2026 23:30
- Source
- 아시아경제
Prestige Biologics extends CB maturity, prolongs overhang concern in Korea - CHOSUNBIZ
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 17 Dec 2025 08:00
- Source
- Chosunbiz
Prestige BioPharma opens Korea’s largest innovative drug R&D center in Busan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Nov 2024 08:00
- Source
- koreabiomed.com
Prestige Biopharma aims to become leading cancer drug developer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jul 2023 07:00
- Source
- BioWorld News
Will Prestige BioPharma's upcoming IPO continue frenzy in bio market?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jan 2021 08:00
- Source
- The Korea Times